The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review

被引:0
|
作者
Arbabzada, Naik [1 ]
Dennett, Liz [1 ,2 ]
Meng, Guanmin [1 ]
Peerani, Farhad [1 ]
机构
[1] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada
[2] Univ Alberta, Geoffrey & Robyn Sperber Hlth Sci Lib, Edmonton, AB, Canada
关键词
primary sclerosing cholangitis; inflammatory bowel disease; oral vancomycin; LIVER-TRANSPLANTATION; ULCERATIVE-COLITIS; BILE-ACID; MICROBIOTA; CHILDREN; TRIAL;
D O I
10.1093/ibd/izae257
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This systematic review summarizes the knowledge on the effectiveness of oral vancomycin in treating inflammatory bowel disease in primary sclerosing cholangitis patients and helps identify knowledge gaps. Ultimately a well-powered randomized controlled trial is required to definitively assess drug efficacy.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis
    Sannaa, Wassel
    Almasry, Mazen
    Peedikayil, Mustafa
    Grimshaw, Alyssa A.
    Attamimi, Mashary
    Almutairdi, Abdulelah
    Al-Bawardy, Badr
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
  • [2] Outcomes of oral vancomycin therapy in patients with primary sclerosing cholangitis and inflammatory bowel disease
    Tan, D.
    Demase, K.
    Little, R.
    Ardalan, Z.
    Taylor, K.
    Sparrow, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 143 - 144
  • [3] Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease
    Cox, KL
    Cox, KM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 27 (05): : 580 - 583
  • [4] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel disease
    Martin, Cristo Yared Perez
    Alonso, Jose Ramon Alberto
    Chavez, Jenifer Gonzalez
    Ruiz, Maria Pilar Diaz
    Gonzalez, Marta Suarez
    Alonso, Javier Merino
    FARMACIA HOSPITALARIA, 2023, 47 (06) : T297 - T299
  • [5] Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease
    Shah, Ayesha
    Burger, Daniel
    Stuart, Katherine
    Martin, Neal
    Walker, Marjorie
    Tallis, Caroline
    Jones, Mike
    Macdonald, Graeme
    Talley, Nicholas
    Morrison, Mark
    Holtmann, Gerald
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 397 - 397
  • [6] Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
    Da Cunha, Teresa
    Vaziri, Haleh
    Wu, George Y.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 531 - 542
  • [7] Effectiveness of Vedolizumab in Patients With Inflammatory Bowel Disease and Concomitant Primary Sclerosing Cholangitis
    Santiago, Priscila
    Robateau, Anthony
    Lopdrup, Rachel G.
    Neto, Manuel B. Braga
    Raffals, Laura
    Eaton, John
    Ramos, Guilherme
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S688 - S689
  • [8] EFFECTIVENESS OF ADALIMUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S799 - S799
  • [9] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E191 - E191
  • [10] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E41 - E41